.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Moodys
QuintilesIMS
US Department of Justice
McKesson
Fish and Richardson
AstraZeneca
Dow
Accenture

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,412,992

« Back to Dashboard

Summary for Patent: 4,412,992

Title: 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
Abstract:The present invention provides a pharmaceutical composition for treating ulcerative colitis containing at least one compound of the general formula: ##STR1## wherein X is an --SO.sub.2 -- or --CO-- group and R is either an unsubstituted or substituted non-heterocyclic aromatic ring system or is a radical of the general formula --(CH.sub.2).sub.n --Y, in which Y is a hydroxyl group, an unsubstituted or substituted amino group or a carboxylic or sulphonic acid group and n is a whole number of from 1 to 6 and in which one or more hydrogen atoms in the alkylene radical can be replaced by unsubstituted or substituted amino groups or alkyl radicals and in which the --(CH.sub.2).sub.n --Y radical is either attached directly to the nitrogen atom or via a benzene ring; and/or containing at least one ester thereof and/or at least one non-toxic, pharmaceutically acceptable salt thereof, in admixture with a solid or liquid pharmaceutical diluent or carrier. Furthermore, the present invention provides a process for preparing the compounds of the above-given general formulae and also provides a method of treating ulcerative colitis.
Inventor(s): Chan; Rosalind P. K. (London, GB2)
Assignee: Biorex Laboratories Limited (GB2)
Application Number:06/281,504
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Delivery;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,412,992

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8023826Jul 21, 1980

International Patent Family for Patent: 4,412,992

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany3128819► Subscribe
France2493312► Subscribe
United Kingdom2080796► Subscribe
Hong Kong31885► Subscribe
Italy1138450► Subscribe
Italy8122859► Subscribe
JapanS5753449► Subscribe
JapanS6225656► Subscribe
Malaysia8600029► Subscribe
Singapore6885► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
Teva
Merck
Express Scripts
Accenture
Medtronic
US Department of Justice
Chubb
Healthtrust
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot